| Dopamine | Altered dopaminergic signaling, particularly in DYT1 and DYT5 dystonia |
| GABA | Reduced inhibitory GABAergic transmission in the basal ganglia |
| Serotonin | Altered serotonin metabolism in some forms |
| Endogenous cannabinoids | Endocannabinoid system involvement in movement control |
| Databases | OMIMOrphanetClinicalTrialsPubMed |